The content of this presentation is provided to an audience of international healthcare professionals from around the world for scientific discussion and scientific exchange. Bayer does not recommend the use of any drug substance outside of its approved indications.
At the moment of publication, the compound presented has been only approved by Food and Drug Administration (FDA) and European Medicines Agency (EMA). For other approvals, follow your local regulations or health authorities legislation.
European Renal Association
60th Annual Meeting June 15–18, 2023
Bayer clinical posters and industry symposium presentation at the 60th European Renal Association annual meeting 2023.
Thank you for your interest ! Please see below to - download powerpoint or watch the session of the presentation of the Bayer Industry Symposia at the ERA Congress 2023 and to - download PDFs and view videos of the posters at ERA 2023 congress. Presentations, Videos and Posters will be available to view following presentation at the congress.
Some of the links to view the Presentations or Posters will link to the official ERA 2023 web page. You may need to be a registered delegate and logged in the respective platform to view the content.
Finerenone
Saturday 17 June, 2023 | 13.35 - 13.45 CET
Non-steroidal MRAs: A new pillar of treatment for cardiorenal protection in CKD and T2D
Nonsteroidal MRAs as part of the comprehensive approach to CKD
Session: Industry Sponsored Symposium Speaker: Beatriz Fernandez
Saturday 17 June, 2023 | 13.45 - 14.00 CET
Non-steroidal MRAs: A new pillar of treatment for cardiorenal protection in CKD and T2D
Pillar approach for the treatment of CKD in T2D: treat early to help prevent further CV and renal damage
Session: Industry Sponsored Symposium Speaker: Christoph Wanner
Saturday 17 June, 2023 | 14.00 - 14.15 CET
Non-steroidal MRAs: A new pillar of treatment for cardiorenal protection in CKD and T2D
Beyond CKD progression: cardiorenal protection across the spectrum of CKD in patients with T2D
Session: Industry Sponsored Symposium Speaker: Rajiv Agarwal
Saturday 17 June, 2023 | 13.35 - 13.45 CET | On Demand
Non-steroidal MRAs: A new pillar of treatment for cardiorenal protection in CKD and T2D
The symposium offers a unique opportunity to gain an overview of the most recent guideline updates related to CKD and T2D and the need for a comprehensive and holistic approach to the patient management. To discuss the use of the ‘pillar approach’ to manage CKD in T2D and how to use finerenone in clinical practice based on expert experience. To highlight the relevance of the urgency to treat CKD in T2D to improve cardiorenal outcomes.
Faculty: Giuseppe Grandaliano (chair), Beatriz Fernandez, Christoph Wanner, Rajiv Agarwal Session: Industry Sponsored Symposium Speaker: Rajiv Agarwal
View Video
17/06/2023 - 8:30 - 9:45 CEST
FINEGUST- Japan; characteristics of medication-initiator cohorts of patients with chronic kidney disease and type 2 diabetes in Japan - a report from FOUNTAIN platform
Session type: focused oral presentation ROOM 6 Presenter: Yuichiro Yano
16/06/2023 - 08:30-09:45 CEST
Validation of a CKD progression risk prediction model in the FIDELITY trial population
Session type: poster / abstract Presenter: Navdeep Tangri
17/06/2023 - 14:45 - 16:00 CEST
REKA: Incidence and frequencies of hyperkalemia in patients with chronic kidney disease: a retrospective database study from US clinical care
Session type: focused oral presentation ROOM 1 Presenter: Van Boemmel-Wegmann
MA-M_FIN-ALL-1229-1